赛伦生物
(688163)
| 流通市值：6.50亿 | | | 总市值：15.84亿 |
| 流通股本：4437.20万 | | | 总股本：1.08亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 26,301,356.47 | 190,144,196.65 | 166,133,808.11 | 93,759,588.31 |
| 营业收入 | 26,301,356.47 | 190,144,196.65 | 166,133,808.11 | 93,759,588.31 |
| 二、营业总成本 | 28,345,641.29 | 150,176,048.43 | 111,754,125.92 | 66,786,383.11 |
| 营业成本 | 7,505,466.73 | 46,187,098.44 | 38,341,848.84 | 23,370,444.36 |
| 税金及附加 | 326,144.02 | 1,533,350.5 | 1,211,571.46 | 756,303.76 |
| 销售费用 | 9,577,697.21 | 53,836,304.92 | 36,980,681.37 | 24,586,402.96 |
| 管理费用 | 5,246,557.71 | 20,513,989.06 | 15,020,766.63 | 10,612,287.25 |
| 研发费用 | 6,202,207.19 | 30,411,906.84 | 22,111,264.41 | 9,002,649.3 |
| 财务费用 | -512,431.57 | -2,306,601.33 | -1,912,006.79 | -1,541,704.52 |
| 其中:利息费用 | 155,793.27 | 648,255.48 | 488,250.27 | 328,245.06 |
| 其中:利息收入 | -657,726.9 | 2,881,192.14 | 2,228,512.02 | 1,651,210.52 |
| 加:公允价值变动收益 | 2,259,676.71 | 2,590,846.58 | 3,124,630.14 | 3,841,328.77 |
| 加:投资收益 | 645,457.55 | 7,743,781.52 | 5,969,609.78 | 4,072,617.12 |
| 资产处置收益 | - | - | - | 11,917.48 |
| 资产减值损失(新) | -365,012.57 | -3,653,259.43 | -2,857,474.01 | -2,165,903.65 |
| 信用减值损失(新) | -637,250.72 | -997,071.15 | -1,979,875.73 | -2,556,554.17 |
| 其他收益 | 2,076,797.24 | 331,534.57 | 248,156.93 | 233,531.93 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,935,383.39 | 45,983,980.31 | 58,884,729.3 | 30,410,142.68 |
| 加:营业外收入 | - | 13,149.49 | 13,149.49 | 0.01 |
| 减:营业外支出 | 19,103.25 | 581,860.6 | 163,220.09 | 47,801.09 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,916,280.14 | 45,415,269.2 | 58,734,658.7 | 30,362,341.6 |
| 减:所得税费用 | 441,493.1 | 6,640,937.57 | 7,936,838.17 | 3,453,017.49 |
| 六、净利润 | 1,474,787.04 | 38,774,331.63 | 50,797,820.53 | 26,909,324.11 |
| 持续经营净利润 | 1,474,787.04 | 38,774,331.63 | 50,797,820.53 | 26,909,324.11 |
| 归属于母公司股东的净利润 | 1,474,787.04 | 38,774,331.63 | 50,797,820.53 | 26,909,324.11 |
| (一)基本每股收益 | 0.01 | 0.36 | 0.47 | 0.25 |
| (二)稀释每股收益 | 0.01 | 0.36 | 0.47 | 0.25 |
| 九、综合收益总额 | 1,474,787.04 | 38,774,331.63 | 50,797,820.53 | 26,909,324.11 |
| 归属于母公司股东的综合收益总额 | 1,474,787.04 | 38,774,331.63 | 50,797,820.53 | 26,909,324.11 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-28 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |